Cytosurge Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
38
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
Cytosurge General Information
Description
Developer of synthetic biology enablers designed to implement advanced genetically engineered cell lines. The company applies a patented single-cell bottom-up gene editing process and dynamic gene expression analysis capabilities to construct, evaluate, and debug complex synthetic mammalian cell lines, thereby empowering genetic engineers to concentrate on designing next-generation gene-edited models.
Contact Information
Website
www.cytosurge.comCorporate Office
- Saegereistrasse 25
- 8152 Glattbrugg
- Switzerland
Corporate Office
- Saegereistrasse 25
- 8152 Glattbrugg
- Switzerland
Cytosurge Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 01-Jul-2026 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2012 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2009 | Completed | Startup |
Cytosurge Patents
Cytosurge Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2024506010-A | How to generate genetically modified cells | Pending | 09-Feb-2021 | ||
| EP-4291668-A1 | Method for producing genetically engineered cells | Pending | 09-Feb-2021 | ||
| US-20240102053-A1 | Method for producing genetically engineered cells | Pending | 09-Feb-2021 | ||
| WO-2022171543-A1 | Method for producing genetically engineered cells | Inactive | 09-Feb-2021 | ||
| EP-4232406-A1 | A method of manufacturing a mems device | Active | 22-Oct-2020 | B81C1/00111 |
Cytosurge Signals
Cytosurge Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Anker Capital (Zug) | Venture Capital | Minority | ||
| ETH Zurich | University |
Cytosurge FAQs
-
When was Cytosurge founded?
Cytosurge was founded in 2009.
-
Where is Cytosurge headquartered?
Cytosurge is headquartered in Glattbrugg, Switzerland.
-
What is the size of Cytosurge?
Cytosurge has 38 total employees.
-
What industry is Cytosurge in?
Cytosurge’s primary industry is Biotechnology.
-
Is Cytosurge a private or public company?
Cytosurge is a Private company.
-
What is Cytosurge’s current revenue?
The current revenue for Cytosurge is .
-
Who are Cytosurge’s investors?
Anker Capital (Zug) and ETH Zurich have invested in Cytosurge.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process